Drug Profile


Alternative Names: SKF 104353; SKF 104353 Z2; SKF S 104353

Latest Information Update: 05 Oct 1998

Price : $50

At a glance

  • Originator GlaxoSmithKline
  • Class Antiallergics; Antiasthmatics; Dicarboxylic acids; Small molecules
  • Mechanism of Action Leukotriene D4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 05 Oct 1998 Discontinued-III for Asthma in USA (Inhalation)
  • 05 Oct 1998 Discontinued-Preclinical for Asthma in Japan (Inhalation)
  • 05 Oct 1998 Discontinued-II for Asthma in Switzerland (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top